With a portfolio of 14 potential blockbuster treatments that it expects to launch over the next five years, GSK is sticking ...

GSK gained after saying it expects to be towards the top end of its financial guidance for 2025 as it posted a 6% jump in ...

BAE Systems also came under pressure, falling 24p to 1797p despite its upgrade to 2025 guidance. GSK also surrendered initial ...

British stocks held steady on Wednesday as investors assessed a mixed bag of corporate earnings while waiting for potential ...

London equities ended Wednesday narrowly mixed as investors weighed stronger-than-expected US economic data against a wave of ...

In the wake of Trump’s global trade war, can the World Trade Organization reclaim its role as guardian of free trade?

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

Euronext Dublin lagged international peers as it finished the day down 1.2 per cent, dragged into the red by food giant Kerry ...

CEO touts 'amazing' sales success of new drug, but firm's stock slumps Montco firm's shares soar on huge sales increase of ...

Wealthy Chinese consumers are likely to spend three times more than their peers on post-retirement healthcare over the next ...

FTSE 100 reaction as HSBC sees profits drop, Nationwide launches benefits line - Stock market news and latest business and ...